Literature DB >> 26257281

THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing.

Kyle A Nilson1, Jiannan Guo2, Michael E Turek2, John E Brogie2, Elizabeth Delaney3, Donal S Luse3, David H Price4.   

Abstract

The Cdk7 subunit of TFIIH phosphorylates RNA polymerase II (Pol II) during initiation, and, while recent studies show that inhibition of human Cdk7 negatively influences transcription, the mechanisms involved are unclear. Using in vitro transcription with nuclear extract, we demonstrate that THZ1, a covalent Cdk7 inhibitor, causes defects in Pol II phosphorylation, co-transcriptional capping, promoter proximal pausing, and productive elongation. THZ1 does not affect initiation but blocks essentially all Pol II large subunit C-terminal domain (CTD) phosphorylation. We found that guanylylation of nascent RNAs is length dependent and modulated by a THZ1-sensitive factor present in nuclear extract. THZ1 impacts pausing through a capping-independent block of DSIF and NELF loading. The P-TEFb-dependent transition into productive elongation was also inhibited by THZ1, likely due to loss of DSIF. Capping and pausing were also reduced in THZ1-treated cells. Our results provide mechanistic insights into THZ1 action and how Cdk7 broadly influences transcription and capping.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26257281      PMCID: PMC4546572          DOI: 10.1016/j.molcel.2015.06.032

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  55 in total

1.  Analysis of RNA polymerase II elongation in vitro.

Authors:  Todd E Adamson; Sarah M Shore; David H Price
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II.

Authors:  Subhrangsu S Mandal; Chun Chu; Tadashi Wada; Hiroshi Handa; Aaron J Shatkin; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

3.  Architecture of the RNA polymerase II-Mediator core initiation complex.

Authors:  C Plaschka; L Larivière; L Wenzeck; M Seizl; M Hemann; D Tegunov; E V Petrotchenko; C H Borchers; W Baumeister; F Herzog; E Villa; P Cramer
Journal:  Nature       Date:  2015-02-04       Impact factor: 49.962

4.  CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.

Authors:  Edmond Chipumuro; Eugenio Marco; Camilla L Christensen; Nicholas Kwiatkowski; Tinghu Zhang; Clark M Hatheway; Brian J Abraham; Bandana Sharma; Caleb Yeung; Abigail Altabef; Antonio Perez-Atayde; Kwok-Kin Wong; Guo-Cheng Yuan; Nathanael S Gray; Richard A Young; Rani E George
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

5.  Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7.

Authors:  F Tirode; D Busso; F Coin; J M Egly
Journal:  Mol Cell       Date:  1999-01       Impact factor: 17.970

6.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.

Authors:  Camilla L Christensen; Nicholas Kwiatkowski; Brian J Abraham; Julian Carretero; Fatima Al-Shahrour; Tinghu Zhang; Edmond Chipumuro; Grit S Herter-Sprie; Esra A Akbay; Abigail Altabef; Jianming Zhang; Takeshi Shimamura; Marzia Capelletti; Jakob B Reibel; Jillian D Cavanaugh; Peng Gao; Yan Liu; Signe R Michaelsen; Hans S Poulsen; Amir R Aref; David A Barbie; James E Bradner; Rani E George; Nathanael S Gray; Richard A Young; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

Review 7.  Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription.

Authors:  Martin Heidemann; Corinna Hintermair; Kirsten Voß; Dirk Eick
Journal:  Biochim Biophys Acta       Date:  2012-09-07

8.  The CDK Network: Linking Cycles of Cell Division and Gene Expression.

Authors:  Robert P Fisher
Journal:  Genes Cancer       Date:  2012-11

9.  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.

Authors:  Kehui Xiang; Takashi Nagaike; Song Xiang; Turgay Kilic; Maia M Beh; James L Manley; Liang Tong
Journal:  Nature       Date:  2010-09-22       Impact factor: 49.962

10.  How an mRNA capping enzyme reads distinct RNA polymerase II and Spt5 CTD phosphorylation codes.

Authors:  Selom K Doamekpor; Ana M Sanchez; Beate Schwer; Stewart Shuman; Christopher D Lima
Journal:  Genes Dev       Date:  2014-06-15       Impact factor: 11.361

View more
  75 in total

Review 1.  Super-Enhancer-Driven Transcriptional Dependencies in Cancer.

Authors:  Satyaki Sengupta; Rani E George
Journal:  Trends Cancer       Date:  2017-04-12

Review 2.  Use of the nuclear walk-on methodology to determine sites of RNA polymerase II initiation and pausing and quantify nascent RNAs in cells.

Authors:  Christopher B Ball; Kyle A Nilson; David H Price
Journal:  Methods       Date:  2019-02-08       Impact factor: 3.608

Review 3.  Super-enhancer function and its application in cancer targeted therapy.

Authors:  Faqing Tang; Zongbei Yang; Yuan Tan; Yuejin Li
Journal:  NPJ Precis Oncol       Date:  2020-02-12

4.  CDK regulation of transcription by RNAP II: Not over 'til it's over?

Authors:  Robert P Fisher
Journal:  Transcription       Date:  2016-12-22

5.  MYC Mediates mRNA Cap Methylation of Canonical Wnt/β-Catenin Signaling Transcripts By Recruiting CDK7 and RNA Methyltransferase.

Authors:  Valeriya Posternak; Matthew H Ung; Chao Cheng; Michael D Cole
Journal:  Mol Cancer Res       Date:  2016-11-29       Impact factor: 5.852

6.  Engineered Covalent Inactivation of TFIIH-Kinase Reveals an Elongation Checkpoint and Results in Widespread mRNA Stabilization.

Authors:  Juan B Rodríguez-Molina; Sandra C Tseng; Shane P Simonett; Jack Taunton; Aseem Z Ansari
Journal:  Mol Cell       Date:  2016-07-28       Impact factor: 17.970

7.  Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer.

Authors:  Yan Zhou; Linlin Lu; Guanmin Jiang; Zhuojia Chen; Jiexin Li; Panpan An; Likun Chen; Jun Du; Hongsheng Wang
Journal:  Cell Death Differ       Date:  2018-11-19       Impact factor: 15.828

8.  Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.

Authors:  Uri Mbonye; Benlian Wang; Giridharan Gokulrangan; Wuxian Shi; Sichun Yang; Jonathan Karn
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

9.  CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.

Authors:  Jae Young Hur; Hyeong Ryul Kim; Jung Yeon Lee; Sojung Park; Ji An Hwang; Woo Sung Kim; Shinkyo Yoon; Chang-Min Choi; Jin Kyung Rho; Jae Cheol Lee
Journal:  Cell Oncol (Dordr)       Date:  2019-03-05       Impact factor: 6.730

10.  O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1β.

Authors:  Melissa Resto; Bong-Hyun Kim; Alfonso G Fernandez; Brian J Abraham; Keji Zhao; Brian A Lewis
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.